Market Cap 266.88M
Revenue (ttm) 0.00
Net Income (ttm) -55.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.19
Volume 948,000
Avg Vol 1,153,774
Day's Range N/A - N/A
Shares Out 47.24M
Stochastic %K 5%
Beta -1.29
Analysts Strong Sell
Price Target $21.00

Latest News on CADL

Candel Therapeutics: Entering Its Pivotal Year

Feb 20, 2025, 10:45 AM EST - 5 weeks ago

Candel Therapeutics: Entering Its Pivotal Year


Best-Performing Stocks Of 2024

Jan 2, 2025, 11:46 PM EST - 3 months ago

Best-Performing Stocks Of 2024

APP BYRN DAVE INOD JANX LUNR MSTR


Candel Therapeutics Announces Pricing of Public Offering

Dec 12, 2024, 11:00 PM EST - 3 months ago

Candel Therapeutics Announces Pricing of Public Offering


Candel Therapeutics Stock Surges Over 100% - Here's Why

Dec 11, 2024, 9:19 AM EST - 3 months ago

Candel Therapeutics Stock Surges Over 100% - Here's Why


Candel Therapeutics' cancer drug meets late-stage trial goals

Dec 11, 2024, 7:09 AM EST - 3 months ago

Candel Therapeutics' cancer drug meets late-stage trial goals


3 Biotech Names With Potential Catalysts By Year End

Jul 29, 2024, 3:32 PM EDT - 8 months ago

3 Biotech Names With Potential Catalysts By Year End

RCKT VRDN


Candel Therapeutics to Join Russell 3000® Index

Jun 11, 2024, 8:00 AM EDT - 10 months ago

Candel Therapeutics to Join Russell 3000® Index


Candel Therapeutics stock soars 30%: find out more

Apr 5, 2024, 8:28 AM EDT - 1 year ago

Candel Therapeutics stock soars 30%: find out more